5E Advanced Materials (FEAM) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jan, 2026Executive summary
Achieved steady-state boric acid production at the small-scale facility, delivering the first truckload sale and exceeding customer quality specifications.
Strategic focus on optimizing operations, reducing costs, and advancing commercial and engineering milestones, including a shift to calcium chloride byproduct.
Expanded commercial team to target U.S. and Asia-Pacific markets, representing 80% of global borate demand.
Completed equity and convertible note offerings, raising $8.6 million, but faces ongoing liquidity challenges and substantial doubt about ability to continue as a going concern.
Received a non-binding LOI from EXIM Bank for up to $285 million in potential debt financing for commercial-scale development.
Financial highlights
Realized first revenue from boric acid sales, credited against small-scale facility operating costs.
Net loss for the quarter ended September 30, 2024 was $12.9 million, a 37% increase year-over-year, with total operating expenses rising 67% to $12.9 million.
Cash and cash equivalents increased to $6.9 million from $4.9 million at June 30, 2024, aided by recent financing activities.
Strategic workforce reduction expected to save $2.2 million in operating expenditures over the next year.
Anticipated 15% reduction in CapEx due to simplified byproduct strategy focused on calcium chloride.
Outlook and guidance
Targeting a financial investment decision (FID) for commercial scale facility by December 2025, following completion of FEED engineering and updated IRR estimates.
Capital estimate from EPC contractor expected by Spring 2025; FEED engineering to follow, lasting 7–8 months.
Boric acid production at the SSF expected to remain at one short ton per day as data is gathered for commercial-scale design.
Expects to secure offtake agreements for 25%-50% of initial 90,000 tons production, with full phase two commitments targeted by spring 2025.
Additional financing required within the next twelve months to maintain compliance with a $7.5 million minimum cash covenant effective December 31, 2024.
Latest events from 5E Advanced Materials
- Net loss improved and key milestones achieved, but ongoing operations require new funding.FEAM
Q2 202617 Feb 2026 - Advancing U.S. boron project targets supply gaps and critical mineral status amid rising demand.FEAM
LD Micro Main Event XIX Investor Conference3 Feb 2026 - Leadership changes and operational progress drive growth and commercial execution.FEAM
Status Update1 Feb 2026 - Raising up to $30M for boron/lithium project, but faces high risk and needs more capital.FEAM
Registration Filing27 Jan 2026 - $10M capital raise and operational milestones set stage for commercial scale-up and offtake deals in 2025.FEAM
Q4 202422 Jan 2026 - Major noteholders may sell up to 41.9M shares after note conversion; company receives no proceeds.FEAM
Registration Filing16 Dec 2025 - Up to 10.7M shares registered for resale via warrants; proceeds support general operations.FEAM
Registration Filing16 Dec 2025 - Registration enables resale of convertible note shares; no proceeds to company; high risk profile.FEAM
Registration Filing16 Dec 2025 - Up to 20.6M shares registered for resale post-restructuring; no proceeds to the company.FEAM
Registration Filing16 Dec 2025